We are monitoring the impact of COVID-19 on North America Regenerative Medicine Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 241
Share on
Share on

North America Regenerative Medicine Market Research Report – Segmented By Product, Therapy, Application & Country (the United States, Canada and Rest of North America) – Industry Analysis on Size, Share, COVID-19 Impact, Trends & Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 241
Pages: 145

North America Regenerative Medicine Market Size (2021 to 2026)

The size of the North America regenerative medicine market is forecasted to be growing at a CAGR of 20.5% from 2021 to 2026 and worth USD 16.47 billion by 2026 from USD 6.48 billion in 2021.

A few of the key drivers that are boosting the growth of the North America regenerative medicine market are rising incidence of bone and joint diseases, growing awareness among the population, the emergence of advanced technologies in tissue engineering and stem cell therapy, rise in demand for regenerative medicines in the treatment of chronic diseases, cancer, and orthopedic disorders, enhancements in nanotechnology, and rise in adoption of CAR-T cell therapies

The North America Regenerative medicine market is further expected to expand at a high pace owing to significant growth opportunities such as increased efforts of researchers to develop regenerative medicines due to unavailability of organs for transplantation, increasing investments in R & D for developing innovative products, significant competitors and research institutes of the market are likely to release a wide range of products in gene therapy and stem cells during the forecast period, potential risks like organ damage or failed functionality that are involved in transplanting organs traditionally, is leading to rising in acceptance of regenerative medicine for transplanting organs.

The factors that diminish the growth of the North America regenerative medicine market are side effects associated with implantation, stringent rules for using human tissues, treatment is costly, growing adoption of cell-based products like stem cells, regulations, and policies on regenerative medicines.

This research report on the North American regenerative medicine market has been segmented and sub-segmented into the following categories:

By Product:

  • Cell-Based Products                            
    • Autologous Cell-Based Products
    • Allogeneic Cell-Based Products  
  • Acellular Products           

By Therapy: 

  • Cell Therapy
  • Gene Therapy
  • Tissue Engineering
  • Immunotherapy

By Application: 

  • Orthopedic & Musculoskeletal Spine                           
  • Dermatology                          
  • Cardiovascular                       
  • Central Nervous System                   
  • Oncology                 
  • Diabetes                  
  • Other Applications

By Country: 

  • The U.S.
  • Canada
  • Rest of North America

Based on the region, the North America regenerative medicine market is predicted to dominate the global market by contributing the largest share of revenue owing to market catalyzing factors such as growing awareness of personalized medicine and emergence of CAR-T cell therapies, increase in investments for developing innovative regenerative drugs, the United States contributes significant share among all of the North American countries owing to the presence of notable market players and research institutes that are developing innovative techniques and availability of high-end technology. In contrast, the Canadian regenerative medicine market is estimated to grow at a higher CAGR during the forecast period.

KEY MARKET PLAYERS:

A few of the promising companies operating in the North American Regenerative Medicines Market profiled in this report are Vertex Pharmaceuticals Incorporated, Acelity L.P. Inc., Celgene Corporation, StemCells, Inc., Organogenesis Inc., NuVasive, Inc., Vericel Corporation (Genzyme), Japan Tissue Engineering Co., Ltd.,  Cytori Therapeutics Inc., Advantagene, Inc. and Mesoblast Ltd.

1. Introduction                                                                                 

                1.1 Market Definition                                                                    

                1.2 Study Deliverables                                                                  

                1.3 Base Currency, Base Year and Forecast Periods                                                                          

                1.4 General Study Assumptions                                                                

2. Research Methodology                                                                                           

                2.1 Introduction                                                                               

                2.2 Research Phases                                                                      

                                2.2.1 Secondary Research                                                           

                                2.2.2 Primary Research                                                 

                                2.2.3 Econometric Modelling                                                      

                                2.2.4 Expert Validation                                                  

                2.3 Analysis Design                                                                         

                2.4 Study Timeline                                                                          

3. Overview                                                                                       

                3.1 Executive Summary                                                                

                3.2 Key Inferences                                                                         

                3.3 New Developments                                                                               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                                                    

                4.1 Market Drivers                                                                          

                4.2 Market Restraints                                                                    

                4.3 Key Challenges                                                                         

                4.4 Current Opportunities in the Market                                                                              

5. Market Segmentation                                                                                              

                5.1 Introduction                                                                               

                5.2 Product                                                                        

                                5.2.1 Introduction                                                           

                                5.2.2 Cell-Based Products                                                            

                                                5.2.2.1 Autologous Cell-Based Products                                

                                                5.2.2.2 Allogeneic Cell-Based Products                                  

                                5.2.3 Acellular Products                                                

                5.3 Therapy                                                                       

                                5.3.1 Introduction                                                           

                                5.3.2 Cell Therapy                                                           

                                5.3.3 Gene Therapy                                                       

                                5.3.4 Tissue Engineering                                                               

                                5.3.5 Immunotherapy                                                   

                5.4 Application                                                                 

                                5.4.1 Introduction                                                           

                                5.4.2 Orthopedic & Musculoskeletal Spine                                                           

                                5.4.3 Dermatology                                                          

                                5.4.4 Cardiovascular                                                       

                                5.4.5 Central Nervous System                                                   

                                5.4.6 Oncology                                                 

                                5.4.7 Diabetes                                                  

                                5.4.8 Other Applications                                                               

6. Geographical Analysis                                                                                              

                                6.1 Introduction                                                               

                                6.2 United States                                                            

                                6.3 Canada                                                         

7. Strategic Analysis                                                                                       

                7.1 PESTLE analysis                                                                         

                                7.1.1 Political                                                     

                                7.1.2 Economic                                                 

                                7.1.3 Social                                                         

                                7.1.4 Technological                                                         

                                7.1.5 Legal                                                          

                                7.1.6 Environmental                                                       

                7.2 Porter’s Five analysis                                                                              

                                7.2.1 Bargaining Power of Suppliers                                                        

                                7.2.2 Bargaining Power of Consumers                                                    

                                7.2.3 Threat of New Entrants                                                     

                                7.2.4 Threat of Substitute Products and Services                                                              

                                7.2.5 Competitive Rivalry within the Industry                                                     

8. Market Leaders' Analysis                                                                                        

                8.1 Vertex Pharmaceuticals Incorporated (U.S.)                                                                

                                8.1.1 Overview                                                 

                                8.1.2 Product Analysis                                                   

                                8.1.3 Strategic Evaluation and Operations                                                            

                                8.1.4 Financial analysis                                                  

                                8.1.5 Legal issues                                                             

                                8.1.6 Recent Developments                                                       

                                8.1.7 SWOT analysis                                                       

                                8.1.8 Analyst View                                                          

                8.2 Acelity L.P. Inc. (U.S.)                                                                             

                8.3 Celgene Corporation (U.S.)                                                                 

                8.4 StemCells, Inc. (U.S.)                                                                              

                8.5 Organogenesis Inc.  (U.S.)                                                                    

                8.6 NuVasive, Inc. (U.S.)                                                                              

                8.7 Vericel Corporation (Genzyme) (U.S.)                                                                            

                8.8 Cytori Therapeutics Inc. (U.S.)                                                                            

                8.9 Advantagene, Inc. (U.S.)                                                                      

                8.10 Mesoblast Ltd. (Australia)                                                                  

9. Competitive Landscape                                                                                           

                9.1 Market share analysis                                                                            

                9.2 Merger and Acquisition Analysis                                                                       

                9.3 Agreements, collaborations and Joint Ventures                                                                         

                9.4 New Product Launches                                                                         

10. Expert Opinions                                                                                        

                10.1 Market Outlook                                                                     

                10.2 Investment Opportunities                                                                 

Appendix                                                                                           

                a) List of Tables                                                                

                b) List of Figures                                                                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. North America Regenerative Medicine Market, By Region, From 2021 to 2026 (USD Million)
  2. North America Regenerative Medicine Market, By Product, From 2021 to 2026 (USD Million)
  3. North America Cell-Based Products Regenerative Medicine Market, By Region, From 2021 to 2026 (USD Million)
  4. North America Acellular Products Regenerative Medicine Market, By Region, From 2021 to 2026 (USD Million)
  5. North America Regenerative Medicine Market, By Therapy, From 2021 to 2026 (USD Million)
  6. North America Cell Therapy Regenerative Medicine Market, By Region, From 2021 to 2026 (USD Million)
  7. North America Gene Therapy Regenerative Medicine Market, By Region, From 2021 to 2026 (USD Million)
  8. North America Tissue Engineering Regenerative Medicine Market, By Region, From 2021 to 2026 (USD Million)
  9. North America Immunotherapy Regenerative Medicine Market, By Region, From 2021 to 2026 (USD Million)
  10. North America Regenerative Medicine Market, By Application, From 2021 to 2026 (USD Million)
  11. North America Orthopedic & Musculoskeletal Spine Regenerative Medicine Market, By Region, From 2021 to 2026 (USD Million)
  12. North America Dermatology Regenerative Medicine Market, By Region, From 2021 to 2026 (USD Million)
  13. North America Cardiovascular Regenerative Medicine Market, By Region, From 2021 to 2026 (USD Million)
  14. North America Central Nervous System Regenerative Medicine Market, By Region, From 2021 to 2026 (USD Million)
  15. North America Oncology Regenerative Medicine Market, By Region, From 2021 to 2026 (USD Million)
  16. North America Diabetes Regenerative Medicine Market, By Region, From 2021 to 2026 (USD Million)
  17. North America Other Applications of Regenerative Medicine Market, By Region, From 2021 to 2026 (USD Million)
  18. United States Regenerative Medicine Market, By Product, From 2021 to 2026 (USD Million)
  19. United States Regenerative Medicine Market, By Therapy, From 2021 to 2026 (USD Million)
  20. United States Regenerative Medicine Market, By Application, From 2021 to 2026 (USD Million)
  21. Canada Regenerative Medicine Market, By Product, From 2021 to 2026 (USD Million)
  22. Canada Regenerative Medicine Market, By Therapy, From 2021 to 2026 (USD Million)
  23. Canada Regenerative Medicine Market, By Application, From 2021 to 2026 (USD Million)
  24. North America Cell-Based Products Regenerative Medicine Market, By Type, From 2021 to 2026 (USD Million)
  25. North America Autologous Cell-Based Products Regenerative Medicine Market, By Region, From 2021 to 2026 (USD Million)
  26. North America Allogeneic Cell-Based Products Regenerative Medicine Market, By Region, From 2021 to 2026 (USD Million)
  27. United States Cell-Based Products Regenerative Medicine Market, By Type, From 2021 to 2026 (USD Million)
  28. Canada Cell-Based Products Regenerative Medicine Market, By Type, From 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample